Liu Jingzhen (fifth from left, first row), chairman of China National Pharmaceutical Group Co, Ltd (Sinopharm), leads a delegation to visit the University of Macao on Feb 26. [Photo/sinopharm.com]

China National Pharmaceutical Group Co, Ltd (Sinopharm), represented by its chairman Liu Jingzhen, visited the University of Macao (UM) on Feb 26, signing a strategic cooperation framework agreement. This agreement aims to deepen collaboration between the two entities and leverage their respective strengths for mutual benefit.

Sinopharm and UM sign a strategic cooperation framework agreement on Feb 26. [Photo/sinopharm.com]

During the visit, Liu introduced Sinopharm's innovative development strategy and emphasized the company's support for the Guangdong-Macao In-Depth Cooperation Zone in Hengqin, Guangdong province.

Highlighting the importance that the central government and the State Council attach to the development of Hengqin and Macao, Liu expressed Sinopharm's commitment to contributing to the region's growth.

The collaboration between Sinopharm and UM aims to establish a joint research institute focusing on biomedicine, traditional Chinese medicine and health. This initiative seeks to foster integration between industry, academia and research, thereby promoting innovation in the life and health industry within the cooperation zone.

Song Yonghua (C), rector of UM, introduces the university's advantages and future development plans to the Sinopharm delegation. [Photo/sinopharm.com]

Song Yonghua, rector of UM, showcased the university's strengths and future development plans, particularly in the field of health sciences.UM is dedicated to enhancing its discipline construction and collaborating with national development strategies to support the biomedical and health industry.

The discussions between the two parties centered on implementing strategic cooperation in specific areas such as biopharmaceuticals, chemical pharmaceuticals, traditional Chinese medicine, and health. Both sides expressed a commitment to realizing project implementation, promoting results transformation and accelerating talent cultivation.

The meeting and signing ceremony signify a comprehensive and substantive partnership between Sinopharm and UM, aligning with the objectives outlined in the 19th CPC National Congress and supporting the "Healthy China" strategy and Macao's "1+4" moderately diversified development strategy.

With the integration and mutual promotion of innovation chains, industrial chains, and talent chains in the medical and health fields, the aim is to create a new paradigm of cooperative innovation in production, education, and research, thereby enhancing the biomedical and health strategies in Hengqin and Macao.

Representatives from UM's Institute of Chinese Medical Sciences, faculty of Health Sciences and Zhuhai UM Science & Technology Research Institute, as well as delegates from Sinopharm's headquarters and subsidiaries, participated in the events.